Lyra Therapeutics Inc Stock Ownership - Who owns Lyra Therapeutics?

Insider buying vs selling

Have Lyra Therapeutics Inc insiders been buying or selling?
Edward T. AndersonDirector2023-05-311,203,612$2.43
Edward T. AndersonDirector2023-05-31197,946$2.43
Edward T. AndersonDirector2023-05-31403,858$2.43
Nbvm GP LLC10% Owner2023-05-311,203,612$2.43
Nbvm GP LLC10% Owner2023-05-31197,946$2.43
Nbvm GP LLC10% Owner2023-05-31403,858$2.43
Perceptive Advisors LLCDirector2023-05-313,610,832$2.49

1 of 1

LYRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LYRA insiders and whales buy or sell their stock.

LYRA Shareholders

What type of owners hold Lyra Therapeutics Inc stock?
Perceptive Advisors LLC25.75%12,757,562$46.82MInstitution
Armistice Capital LLC8.10%4,012,036$14.72MInstitution
Nantahala Capital Management LLC7.99%3,957,542$14.52MInstitution
Citadel Advisors LLC5.75%2,849,178$10.46MInstitution
Samsara Biocapital LLC5.61%2,780,261$10.20MInstitution
Edward T. Anderson5.33%2,640,228$9.69MInsider
Perceptive Advisors LLC5.20%2,576,892$9.46MInsider
Nbvm GP LLC5.09%2,521,745$9.25MInsider
Pura Vida Investments LLC2.85%1,413,242$5.19MInstitution
Ikarian Capital LLC1.98%978,626$3.59MInstitution

1 of 3

LYRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LYRA68.02%16.86%Net Buying
LRMR43.87%56.13%Net Buying
ATRA88.76%8.36%Net SellingNet Selling
GOSS27.52%14.43%Net BuyingNet Buying

Lyra Therapeutics Stock Ownership FAQ

Who owns Lyra Therapeutics?

Lyra Therapeutics (NASDAQ: LYRA) is owned by 68.02% institutional shareholders, 16.86% Lyra Therapeutics insiders, and 15.13% retail investors. Edward T. Anderson is the largest individual Lyra Therapeutics shareholder, owning 2.64M shares representing 5.33% of the company. Edward T. Anderson's Lyra Therapeutics shares are currently valued at $9.69M.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.